Onconova Therapeutics Inc.
375 Pheasant Run
Newtown
New Jersey
18940
United States
Tel: 609-844-7735
Website: http://www.onconova.com/
Email: info@onconova.com
230 articles about Onconova Therapeutics Inc.
-
The Leukemia & Lymphoma Society and Onconova Therapeutics Inc. Enter Partnership to Advance Clinical Development of ESTYBON(TM) in High Risk Myelodysplastic Syndrome Patients
6/1/2010
-
Onconova Therapeutics Inc. Announces Presentation of Clinical Proof of Concept of ON 01910.Na in Patients with High Risk Myelodysplastic Syndrome (MDS) at American Society of Hematology 2009 Annual Meeting
12/7/2009
-
Onconova Therapeutics Inc. Announces Presentation of Nonclinical Data on Lead Compound ON 01910.Na and New Jak 2/Bcr-abl Inhibitors at American Association for Cancer Research
4/22/2009
-
Onconova Therapeutics Inc. Announces Initiation of Phase I Clinical Testing for Ex-RAD(TM), a Radioprotective Drug
1/23/2009
-
Onconova Therapeutics Inc. and DoD Collaborators Publish Research Demonstrating Increased Survivability of Previously Lethal Radiation in Mice with New Radioprotective Drug Ex-RAD(TM)
1/23/2009
-
Onconova Therapeutics Inc. Announces Publication of Positive Phase I Results for Lead Anticancer Compound in Journal of Clinical Oncology
10/28/2008
-
Onconova Therapeutics Inc. Announces Presentation of Clinical and Nonclinical Data on Lead Compound ON 01910.Na and New Sulfonamide Compounds at American Association for Cancer Research
4/11/2008
-
Onconova Therapeutics Inc. Announces Presentation of Clinical and Non-Clinical Results for Its Lead Compound ON 01910.Na at American Association for Cancer Research Conference in Los Angeles
4/16/2007
-
Onconova Therapeutics Inc. Release: Data Presented On Anti-Cancer Compound ON 01910.Na At American Society of Clinical Oncology Conference
6/5/2006
-
Michael Hoffman Is Elected Chairman Of The Board For Onconova Therapeutics Inc.
5/30/2006